- Neuroprotection in an experimental model of multiple sclerosis via fatty acid amide hydrolase or monoacylglycerol lipase inhibition
G Pryce, R Graves, M R Elphick, G Giovannoni, D Baker
- Neuroprotection in an experimental model of multiple sclerosis via fatty acid amide hydrolase or monoacylglycerol lipase inhibition
G Pryce, R Graves, M R Elphick, G Giovannoni, D Baker
- Neuroprotection in an experimental model of multiple sclerosis via opening of big conductance, calcium-activated potassium channels
D Baker, G Pryce, S Sisay, G Giovannoni, D L Selwood
- Neuroprotection in an experimental model of multiple sclerosis via opening of big conductance, calcium-activated potassium channels
D Baker, G Pryce, S Sisay, G Giovannoni, D L Selwood
- Perinatal neuroprotection of cannabidiol-treated developing rats after repeated bicuculline-induced seizures
F J Alvarez, H Lafuente, A A Alvarez, E Hilario, W Hind, J Martinez-Orgado
- Perinatal neuroprotection of cannabidiol-treated developing rats after repeated bicuculline-induced seizures
F J Alvarez, H Lafuente, A A Alvarez, E Hilario, W Hind, J Martinez-Orgado
- Possible contribution of Cannabinoid CB1 receptors as a pharmacotherapy for clozapine-induced weight gain in rat model of schizophrenia
F Batool, A Shah
- Possible contribution of Cannabinoid CB1 receptors as a pharmacotherapy for clozapine-induced weight gain in rat model of schizophrenia
F Batool, A Shah
- PUFA N-acylethanolamines increase intracellular calcium through cannabinoid and TRPV1 receptors
N Alharthi, S P Alexander
- PUFA N-acylethanolamines increase intracellular calcium through cannabinoid and TRPV1 receptors
N Alharthi, S P Alexander
